Literature DB >> 29967020

Broad-Spectrum Adaptive Antibiotic Resistance Associated with Pseudomonas aeruginosa Mucin-Dependent Surfing Motility.

Evelyn Sun1, Erin E Gill1, Reza Falsafi1, Amy Yeung1, Sijie Liu1, Robert E W Hancock2.   

Abstract

Surfing motility is a novel form of surface adaptation exhibited by the nosocomial pathogen Pseudomonas aeruginosa in the presence of the glycoprotein mucin, which is found in high abundance at mucosal surfaces, especially those of the lungs of cystic fibrosis and bronchiectasis patients. Here, we investigated the adaptive antibiotic resistance of P. aeruginosa under conditions in which surfing occurs compared that in to cells undergoing swimming. P. aeruginosa surfing cells were significantly more resistant to several classes of antibiotics, including aminoglycosides, carbapenems, polymyxins, and fluoroquinolones. This was confirmed by incorporation of antibiotics into growth medium, which revealed a concentration-dependent inhibition of surfing motility that occurred at concentrations much higher than those needed to inhibit swimming. To investigate the basis of resistance, transcriptome sequencing (RNA-Seq) was performed and revealed that surfing influenced the expression of numerous genes. Included among genes dysregulated under surfing conditions were multiple genes from the Pseudomonas resistome; these genes are known to affect antibiotic resistance when mutated. Screening transposon mutants in these surfing-dysregulated resistome genes revealed that several of these mutants exhibited changes in susceptibility to one or more antibiotics under surfing conditions, consistent with a contribution to the observed adaptive resistance. In particular, several mutants in resistome genes, including armR, recG, atpB, clpS, nuoB, and certain hypothetical genes, such as PA5130, PA3576, and PA4292, showed contributions to broad-spectrum resistance under surfing conditions and could be complemented by their respective cloned genes. Therefore, we propose that surfing adaption led to extensive multidrug adaptive resistance as a result of the collective dysregulation of diverse genes.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  adaptive resistance; antibiotic resistance; cystic fibrosis; mucin; resistome; surfing

Mesh:

Substances:

Year:  2018        PMID: 29967020      PMCID: PMC6125533          DOI: 10.1128/AAC.00848-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

Review 1.  Pseudomonas aeruginosa: all roads lead to resistance.

Authors:  Elena B M Breidenstein; César de la Fuente-Núñez; Robert E W Hancock
Journal:  Trends Microbiol       Date:  2011-06-12       Impact factor: 17.079

Review 2.  Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance.

Authors:  Javier Garau; Dave P Nicolau; Björn Wullt; Matteo Bassetti
Journal:  J Glob Antimicrob Resist       Date:  2014-09-16       Impact factor: 4.035

3.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

4.  ATP-dependent RecG helicase is required for the transcriptional regulator OxyR function in Pseudomonas species.

Authors:  Jinki Yeom; Yunho Lee; Woojun Park
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

5.  Mucin promotes rapid surface motility in Pseudomonas aeruginosa.

Authors:  Amy T Y Yeung; Alicia Parayno; Robert E W Hancock
Journal:  mBio       Date:  2012-05-01       Impact factor: 7.867

6.  Gene expression in Pseudomonas aeruginosa swarming motility.

Authors:  Julien Tremblay; Eric Déziel
Journal:  BMC Genomics       Date:  2010-10-20       Impact factor: 3.969

7.  Genome-scale identification of resistance functions in Pseudomonas aeruginosa using Tn-seq.

Authors:  Larry A Gallagher; Jay Shendure; Colin Manoil
Journal:  mBio       Date:  2011-01-18       Impact factor: 7.867

Review 8.  Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review.

Authors:  Ana Margarida Sousa; Maria Olívia Pereira
Journal:  Pathogens       Date:  2014-08-18

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

Review 10.  New antibiotics for bad bugs: where are we?

Authors:  Matteo Bassetti; Maria Merelli; Chiara Temperoni; Augusta Astilean
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-08-28       Impact factor: 3.944

View more
  11 in total

1.  Analysis of the Pseudomonas aeruginosa Aminoglycoside Differential Resistomes Allows Defining Genes Simultaneously Involved in Intrinsic Antibiotic Resistance and Virulence.

Authors:  Fernando Sanz-García; Carolina Alvarez-Ortega; Jorge Olivares-Pacheco; Paula Blanco; José Luis Martínez; Sara Hernando-Amado
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Antibacterial and antibiofilm activity of Peganum harmala seed extract against multidrug-resistant Pseudomonas aeruginosa pathogenic isolates and molecular mechanism of action.

Authors:  Nadine Khadraoui; Rym Essid; Selim Jallouli; Bilel Damergi; Iheb Ben Takfa; Ghassen Abid; Ines Jedidi; Asma Bachali; Ameni Ayed; Ferid Limam; Olfa Tabbene
Journal:  Arch Microbiol       Date:  2022-01-09       Impact factor: 2.552

3.  A novel mouse model of chronic suppurative otitis media and its use in preclinical antibiotic evaluation.

Authors:  Kelly M Khomtchouk; Ali Kouhi; Anping Xia; Laurent Adonis Bekale; Solange M Massa; Jolien M Sweere; Daniel Pletzer; Robert E Hancock; Paul L Bollyky; Peter L Santa Maria
Journal:  Sci Adv       Date:  2020-08-14       Impact factor: 14.136

4.  Surfing Motility: a Conserved yet Diverse Adaptation among Motile Bacteria.

Authors:  Evelyn Sun; Sijie Liu; Robert E W Hancock
Journal:  J Bacteriol       Date:  2018-11-06       Impact factor: 3.490

5.  Amikacin and bacteriophage treatment modulates outer membrane proteins composition in Proteus mirabilis biofilm.

Authors:  Agnieszka Maszewska; Magdalena Moryl; Junli Wu; Bin Liu; Lu Feng; Antoni Rozalski
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

6.  Impact of the Epithelial Lining Fluid Milieu on Amikacin Pharmacodynamics Against Pseudomonas aeruginosa.

Authors:  Aaron J Heffernan; Fekade B Sime; Sazlyna Mohd Sazlly Lim; Saiyuri Naicker; Katherine T Andrews; David Ellwood; Jeffrey Lipman; Keith Grimwood; Jason A Roberts
Journal:  Drugs R D       Date:  2021-04-02

7.  Characterization of Putative Virulence Factors of Pseudomonas aeruginosa Strain RBS Isolated from a Saltern, Tunisia: Effect of Metal Ion Cofactors on the Structure and the Activity of LasB.

Authors:  E Rigane; R Dutoit; S Matthijs; N Brandt; S Flahaut; K S Belghith
Journal:  Biomed Res Int       Date:  2020-07-23       Impact factor: 3.411

8.  Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics.

Authors:  Ariane Khaledi; Aaron Weimann; Monika Schniederjans; Ehsaneddin Asgari; Tzu-Hao Kuo; Antonio Oliver; Gabriel Cabot; Axel Kola; Petra Gastmeier; Michael Hogardt; Daniel Jonas; Mohammad Rk Mofrad; Andreas Bremges; Alice C McHardy; Susanne Häussler
Journal:  EMBO Mol Med       Date:  2020-02-12       Impact factor: 12.137

9.  Surfing motility is a complex adaptation dependent on the stringent stress response in Pseudomonas aeruginosa LESB58.

Authors:  Daniel Pletzer; Evelyn Sun; Caleb Ritchie; Lauren Wilkinson; Leo T Liu; Michael J Trimble; Heidi Wolfmeier; Travis M Blimkie; Robert E W Hancock
Journal:  PLoS Pathog       Date:  2020-03-24       Impact factor: 6.823

Review 10.  The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies.

Authors:  R Frèdi Langendonk; Daniel R Neill; Joanne L Fothergill
Journal:  Front Cell Infect Microbiol       Date:  2021-04-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.